Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-312024-01-01falseNo description of principal activity6164truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 02841841 2024-01-01 2024-12-31 02841841 2023-01-01 2023-12-31 02841841 2024-12-31 02841841 2023-12-31 02841841 c:Director2 2024-01-01 2024-12-31 02841841 c:RegisteredOffice 2024-01-01 2024-12-31 02841841 d:Buildings d:LongLeaseholdAssets 2024-01-01 2024-12-31 02841841 d:Buildings d:LongLeaseholdAssets 2024-12-31 02841841 d:Buildings d:LongLeaseholdAssets 2023-12-31 02841841 d:PlantMachinery 2024-01-01 2024-12-31 02841841 d:PlantMachinery 2024-12-31 02841841 d:PlantMachinery 2023-12-31 02841841 d:PlantMachinery d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 02841841 d:FurnitureFittings 2024-01-01 2024-12-31 02841841 d:FurnitureFittings 2024-12-31 02841841 d:FurnitureFittings 2023-12-31 02841841 d:FurnitureFittings d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 02841841 d:ComputerEquipment 2024-01-01 2024-12-31 02841841 d:ComputerEquipment 2024-12-31 02841841 d:ComputerEquipment 2023-12-31 02841841 d:ComputerEquipment d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 02841841 d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 02841841 d:ComputerSoftware 2024-12-31 02841841 d:ComputerSoftware 2023-12-31 02841841 d:CurrentFinancialInstruments 2024-12-31 02841841 d:CurrentFinancialInstruments 2023-12-31 02841841 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 02841841 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 02841841 d:ShareCapital 2024-12-31 02841841 d:ShareCapital 2023-12-31 02841841 d:RetainedEarningsAccumulatedLosses 2024-12-31 02841841 d:RetainedEarningsAccumulatedLosses 2023-12-31 02841841 d:AcceleratedTaxDepreciationDeferredTax 2024-12-31 02841841 d:AcceleratedTaxDepreciationDeferredTax 2023-12-31 02841841 d:RetirementBenefitObligationsDeferredTax 2024-12-31 02841841 d:RetirementBenefitObligationsDeferredTax 2023-12-31 02841841 c:OrdinaryShareClass1 2024-01-01 2024-12-31 02841841 c:OrdinaryShareClass1 2024-12-31 02841841 c:OrdinaryShareClass1 2023-12-31 02841841 c:FRS102 2024-01-01 2024-12-31 02841841 c:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 02841841 c:FullAccounts 2024-01-01 2024-12-31 02841841 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 02841841 2 2024-01-01 2024-12-31 02841841 d:ComputerSoftware d:OwnedIntangibleAssets 2024-01-01 2024-12-31 02841841 e:PoundSterling 2024-01-01 2024-12-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 02841841









LYNDEN HILL CLINICS LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2024

 
LYNDEN HILL CLINICS LIMITED
 
 
COMPANY INFORMATION


Director
D F Alzeera 




Registered number
02841841



Registered office
Linden Hill Lane
Kiln Green

Berkshire

RG10 9XP




Accountants
Donald Reid Limited

1010 Eskdale Road

Winnersh

Wokingham

England

RG41 5TS





 
LYNDEN HILL CLINICS LIMITED
 

CONTENTS



Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 12


 
LYNDEN HILL CLINICS LIMITED
REGISTERED NUMBER: 02841841

BALANCE SHEET
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Intangible assets
 4 
1,769
2,641

Tangible assets
 5 
766,000
527,241

  
767,769
529,882

Current assets
  

Debtors: amounts falling due within one year
 6 
216,666
150,320

Cash at bank and in hand
 7 
583,283
730,255

  
799,949
880,575

Creditors: amounts falling due within one year
 8 
(440,087)
(406,373)

Net current assets
  
 
 
359,862
 
 
474,202

Total assets less current liabilities
  
1,127,631
1,004,084

Provisions for liabilities
  

Deferred tax
 9 
(85,598)
(65,532)

  
 
 
(85,598)
 
 
(65,532)

Net assets
  
1,042,033
938,552


Capital and reserves
  

Called up share capital 
 10 
100,000
100,000

Profit and loss account
  
942,033
838,552

  
1,042,033
938,552


Page 1

 
LYNDEN HILL CLINICS LIMITED
REGISTERED NUMBER: 02841841
    
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2024

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 30 September 2025.



D F Alzeera
Director

The notes on pages 3 to 12 form part of these financial statements.

Page 2

 
LYNDEN HILL CLINICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

Lynden Hill Clinics Limited is a private company limited by shares. The company is registered in England and Wales and was incorporated in the United Kingdom. The registration number is 02841841. The registered office is Linden Hill Lane, Kiln Green, Berkshire, RG10 9XP.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Operating leases: the Company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

Page 3

 
LYNDEN HILL CLINICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.6

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.7

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


 
2.8

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

Page 4

 
LYNDEN HILL CLINICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.9

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Long-term leasehold property
-
Plant and machinery
-
20%
Reducing balance
Fixtures and fittings
-
20%
Reducing balance
Computer equipment
-
33%
Reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.10

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.11

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.12

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.13

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

Page 5

 
LYNDEN HILL CLINICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.14

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

The Company has elected to apply the recognition and measurement provisions of IFRS 9 Financial Instruments (as adopted by the UK Endorsement Board) with the disclosure requirements of Sections 11 and 12 and the other presentation requirements of FRS 102.

Financial instruments are recognised in the Company's Balance sheet when the Company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Other financial assets

Other financial assets, which includes investments in equity instruments which are not classified as subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the recognised transaction price. Such assets are subsequently measured at fair value with the changes in fair value being recognised in the profit or loss. Where other financial assets are not publicly traded, hence their fair value cannot be measured reliably, they are measured at cost less impairment.

Impairment of financial assets

At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss. 

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The
Page 6

 
LYNDEN HILL CLINICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)


2.14
Financial instruments (continued)

impairment reversal is recognised in the profit or loss.

Basic financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Other financial instruments

Derivatives, including forward exchange contracts, futures contracts and interest rate swaps, are not classified as basic financial instruments. These are initially recognised at fair value on the date the derivative contract is entered into, with costs being charged to the profit or loss. They are subsequently measured at fair value with changes in the profit or loss.

Debt instruments that do not meet the conditions as set out in FRS 102 paragraph 11.9 are subsequently measured at fair value through the profit or loss. This recognition and measurement would also apply to financial instruments where the performance is evaluated on a fair value basis as with a documented risk management or investment strategy.


3.


Employees

The average monthly number of employees, including the director, during the year was as follows:


        2024
        2023
            No.
            No.







Employees
61
64

Page 7

 
LYNDEN HILL CLINICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

4.


Intangible assets




Computer software

£



Cost


At 1 January 2024
14,893



At 31 December 2024

14,893



Amortisation


At 1 January 2024
12,252


Charge for the year on owned assets
872



At 31 December 2024

13,124



Net book value



At 31 December 2024
1,769



At 31 December 2023
2,641



Page 8

 
LYNDEN HILL CLINICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

5.


Tangible fixed assets





Long-term leasehold property
Plant and machinery
Fixtures and fittings
Computer equipment
Total

£
£
£
£
£



Cost or valuation


At 1 January 2024
-
252,776
579,921
36,777
869,474


Additions
390,139
8,124
9,785
323
408,371



At 31 December 2024

390,139
260,900
589,706
37,100
1,277,845



Depreciation


At 1 January 2024
-
139,232
180,817
22,184
342,233


Charge for the year on owned assets
60,570
23,336
80,881
4,825
169,612



At 31 December 2024

60,570
162,568
261,698
27,009
511,845



Net book value



At 31 December 2024
329,569
98,332
328,008
10,091
766,000



At 31 December 2023
-
113,544
399,104
14,593
527,241

Page 9

 
LYNDEN HILL CLINICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

6.


Debtors

2024
2023
£
£


Trade debtors
108,253
58,660

Other debtors
68,193
19,865

Prepayments and accrued income
19,154
65,307

Tax recoverable
21,066
6,488

216,666
150,320





7.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
583,283
730,255

583,283
730,255



8.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
110,372
194,265

Corporation tax
65,617
86,840

Other taxation and social security
33,918
26,202

Other creditors
65,384
94,866

Accruals and deferred income
164,796
4,200

440,087
406,373


Page 10

 
LYNDEN HILL CLINICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

9.


Deferred taxation




2024


£






At beginning of year
(65,532)


Charged to profit or loss
(20,066)



At end of year
(85,598)

The provision for deferred taxation is made up as follows:

2024
2023
£
£


Accelerated capital allowances
(87,226)
(66,307)

Pension surplus
1,628
775

(85,598)
(65,532)


10.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



100,000 (2023 - 100,000) Ordinary shares of £1.00 each
100,000
100,000



11.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £36,793 (2023: £39,337).Contributions totalling £16,307 (2023: £7,936) were payable to the fund at the balance sheet date and are included in creditors. 


12.


Transactions with directors

During the period, advances of £25,606 (2023: £420) and repayments of £2,000 (2023: £Nil) were made to the director. Interest was charged at the official rate.

Page 11

 
LYNDEN HILL CLINICS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

13.


Related party transactions

During the year, rent of £322,000 (2023: £167,901) has been charged by the parent company. 
At the year-end, included in other debtors is £43,193 
(2023: £19,587) owed to the company by a director.

 
Page 12